Astrana Health reported third-quarter revenue of $1,023.6 million, a 7% increase year-over-year, alongside record adjusted EBITDA of $77.2 million, up 13%. Net income attributable to the company reached $13.0 million, or $0.26 per diluted share, compared to $0.4 million and $0.01 in the prior-year period. For the nine months ended September 30, 2026, revenue grew 33% to $2,961.2 million with adjusted EBITDA of $212.4 million. The company narrowed its full-year 2026 guidance, projecting total revenue between $3.9 billion and $4.0 billion and adjusted EBITDA between $261 million and $274 million. Astrana Health is a physician-centric, technology-enabled healthcare company that empowers providers to deliver accessible, high-quality care through value-based arrangements.
